Professor Paul Nghiem

Paul Nghiem, M.D., Ph.D. is Associate Professor, Skin Cancer and Cell Cycle Biology, Fred Hutchinson Cancer Research Center, University of Washington Medical School.
 
Paul has 3 areas of clinical interest. They are:

• Merkel cell carcinoma
• Melanoma / cutaneous oncology
• Graft versus host disease/skin inflammation

A major portion of his lab is focused on basic, clinical, and translational research aspects of Merkel cell carcinoma. He is involved in several clinical studies on this increasingly common and often lethal skin cancer to determine its basic genetic underpinnings as well as its clinical course and optimal management. The Merkel cell carcinoma Multicenter Interest Group (MMIG), an international collaborative group, has been formed to leverage diverse resources, interests, and expertise to make a difference in this cancer.
 
Paul coauthored Effect of Caffeine on the ATR/Chk1 Pathway in the Epidermis of UVB-Irradiated Mice, Protection from photodamage by topical application of caffeine after UV, Elucidating biological systems with small molecules, A Robust Small-molecule Microarray Platform for Screening Cell Lysates, Human Immunodeficiency Virus Type I Vpr-mediated G2 Arrest Requires Rad 17 and Hus1 and Induces Nuclear BRCA1 and Gamma-H2AX focus formation, Protein Kinases as Targets in Cancer Therapy: Validated and Emerging Approaches, and Integration of Growth Factor and Nutrient Signaling: Implications for Cancer Biology.
 
Paul earned his B.A. in Biological Sciences at Harvard University in 1986, his M.D. at Stanford University in 1994, and his Ph.D. in Cancer Biology at Stanford University in 1994.
 
Read Burlington man survives bout with rare skin cancer.